Legal status by country
Is Young Plasma Infusion legal?
Written by Aaron CuhaReviewed Sep 2026
How Young Plasma Infusion is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Approved | Approved | Approved |
| Classification | Licensed blood component; infusion for ageing is an unapproved use | Licensed blood component; not licensed for ageing indications | Licensed blood component; not registered for ageing indications | Licensed blood component; not approved for ageing indications |
| Note | FDA consumer statement of 19 February 2019 advises caution about establishments selling young donor plasma infusions. | None recorded | None recorded | None recorded |
US FDA status: Plasma is a licensed blood component with defined clinical indications in coagulation and plasma exchange. Infusion for ageing, memory loss or neurodegeneration is not an approved use. FDA published a consumer warning about clinics selling it on 19 February 2019.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.